DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 8.04% to $9.15 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.84% to 25,870.71 and Dow Jones Industrial Average falling 0.65% to 49,363.88.
This was the stock's fourth consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 55.50% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.48% to $5.99, Fortress Biotech Inc. (FBIO) rose 2.02% to $2.53, and Viking Therapeutics Inc. (VKTX) fell 1.01% to $28.40.
Trading volume (324,136) eclipsed its 50-day average volume of 264,933.
Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 19, 2026 17:19 ET (21:19 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments